These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 25456162)
1. Ovarian response is affected by a specific histidine-rich glycoprotein polymorphism: a preliminary study. Nordqvist S; Kårehed K; Skoog Svanberg A; Menezes J; Åkerud H Reprod Biomed Online; 2015 Jan; 30(1):74-81. PubMed ID: 25456162 [TBL] [Abstract][Full Text] [Related]
2. The effect of a specific histidine-rich glycoprotein polymorphism on male infertility and semen parameters. Lindgren KE; Nordqvist S; Kårehed K; Sundström-Poromaa I; Åkerud H Reprod Biomed Online; 2016 Aug; 33(2):180-8. PubMed ID: 27210772 [TBL] [Abstract][Full Text] [Related]
3. Histidine-rich glycoprotein polymorphism and pregnancy outcome: a pilot study. Nordqvist S; Kårehed K; Stavreus-Evers A; Akerud H Reprod Biomed Online; 2011 Aug; 23(2):213-9. PubMed ID: 21665544 [TBL] [Abstract][Full Text] [Related]
4. Effects of HRG and TP73 gene variations on ovarian response. Bakay K; Coban U; Arslan MA; Guven D; Tural S Gynecol Endocrinol; 2022 Mar; 38(3):243-247. PubMed ID: 34494506 [TBL] [Abstract][Full Text] [Related]
5. Histidine-rich glycoprotein derived peptides affect endometrial angiogenesis in vitro but has no effect on embryo development. Lindgren KE; Hreinsson J; Helmestam M; Wånggren K; Poromaa IS; Kårehed K; Åkerud H Syst Biol Reprod Med; 2016 Jun; 62(3):192-200. PubMed ID: 27030529 [TBL] [Abstract][Full Text] [Related]
6. HRG C633T polymorphism and risk of gestational hypertensive disorders: a pilot study. Elenis E; Skalkidou A; Skoog-Svanberg A; Sydsjö G; Stavreus-Evers A; Åkerud H BMC Med Genet; 2018 Mar; 19(1):44. PubMed ID: 29540166 [TBL] [Abstract][Full Text] [Related]
8. Association of histidine-rich glycoprotein C633T single nucleotide polymorphism and recurrent miscarriage in Iranian women. Latifimehr M; Rastegari AA; Zamani Z; Fard-Esfahani P; Nazari L Mol Biol Rep; 2024 Jul; 51(1):793. PubMed ID: 39001985 [TBL] [Abstract][Full Text] [Related]
9. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. Hohmann FP; Macklon NS; Fauser BC J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847 [TBL] [Abstract][Full Text] [Related]
10. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer]. Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109 [TBL] [Abstract][Full Text] [Related]
11. Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles. Zangmo R; Singh N; Kumar S; Vanamail P; Tiwari A Reprod Biomed Online; 2014 Jun; 28(6):743-7. PubMed ID: 24745834 [TBL] [Abstract][Full Text] [Related]
12. Impact of ovarian endometrioma on oocytes and pregnancy outcome in in vitro fertilization. Suzuki T; Izumi S; Matsubayashi H; Awaji H; Yoshikata K; Makino T Fertil Steril; 2005 Apr; 83(4):908-13. PubMed ID: 15820799 [TBL] [Abstract][Full Text] [Related]
13. Deep pelvic endometriosis negatively affects ovarian reserve and the number of oocytes retrieved for in vitro fertilization. Papaleo E; Ottolina J; Viganò P; Brigante C; Marsiglio E; De Michele F; Candiani M Acta Obstet Gynecol Scand; 2011 Aug; 90(8):878-84. PubMed ID: 21542809 [TBL] [Abstract][Full Text] [Related]
14. A high number of oocytes obtained after ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection is not associated with decreased pregnancy outcome. Kok JD; Looman CW; Weima SM; te Velde ER Fertil Steril; 2006 Apr; 85(4):918-24. PubMed ID: 16580375 [TBL] [Abstract][Full Text] [Related]
15. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study. Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834 [TBL] [Abstract][Full Text] [Related]
16. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined? Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979 [TBL] [Abstract][Full Text] [Related]
17. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization. Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155 [TBL] [Abstract][Full Text] [Related]
18. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924 [TBL] [Abstract][Full Text] [Related]
19. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation]. Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561 [TBL] [Abstract][Full Text] [Related]
20. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Klinkert ER; te Velde ER; Weima S; van Zandvoort PM; Hanssen RG; Nilsson PR; de Jong FH; Looman CW; Broekmans FJ Reprod Biomed Online; 2006 Nov; 13(5):687-95. PubMed ID: 17169182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]